CIK 0001401667 · Accelerated filer<br>Smaller reporting company
PUMA BIOTECHNOLOGY, INC.
Sign in to watch- Ticker
- PBYI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770683487
- Phone
- (424) 248-6500
- Business address
- 10880 WILSHIRE BLVD., SUITE 1700, LOS ANGELES, CA
- Former names
- INNOVATIVE ACQUISITIONS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $612,494
- in 2 filings, $612K under 10b5-1 plans
Net −$612,494. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-13 | WILSON TROY EDWARD Director | Sale 10b5-1 | −27,000 | $3.33 | $90K | 350 |
| 2024-06-13 | Stuglik Brian M Director | Sale 10b5-1 | −9,900 | $3.39 | $34K | 49,058 |
| 2024-06-13 | Senderowicz Adrian Director | Sale 10b5-1 | −27,000 | $3.33 | $90K | 0 |
| 2024-06-13 | MOYES JAY M Director | Sale 10b5-1 | −22,000 | $3.34 | $73K | 21,322 |
| 2024-06-13 | Dorval Allison Director | Sale 10b5-1 | −11,000 | $3.37 | $37K | 33,000 |
| 2024-03-15 | AUERBACH ALAN H President and CEO | Grant or award | +6,577 | 7,104,320 | ||
| 2024-03-15 | AUERBACH ALAN H President and CEO | Grant or award · Stock Option (Right to Buy) | +9,047 | 9,047 | ||
| 2024-02-12 | Wong Alvin F Chief Scientific Officer | Grant or award | +43,307 | 141,241 | ||
| 2024-02-12 | Wong Alvin F Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +59,946 | 59,946 | ||
| 2024-02-12 | NOUGUES MAXIMO F Chief Financial Officer | Grant or award | +43,307 | 171,973 | ||
| 2024-02-12 | NOUGUES MAXIMO F Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +59,946 | 59,946 | ||
| 2024-02-12 | Ludwig Jeffrey Jerome Chief Commercial Officer | Grant or award | +27,067 | 127,037 | ||
| 2024-02-12 | Ludwig Jeffrey Jerome Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +37,466 | 37,466 | ||
| 2024-02-12 | AUERBACH ALAN H President and CEO | Grant or award | +160,796 | 7,097,743 | ||
| 2024-02-12 | AUERBACH ALAN H President and CEO | Grant or award · Stock Option (Right to Buy) | +222,573 | 222,573 | ||
| 2024-02-12 | HUNT DOUGLAS M See Remarks | Grant or award | +37,894 | 141,213 | ||
| 2024-02-12 | HUNT DOUGLAS M See Remarks | Grant or award · Stock Option (Right to Buy) | +52,452 | 52,452 | ||
| 2024-01-03 | Wong Alvin F Chief Scientific Officer | Sale 10b5-1 | −7,733 | $4.49 | $35K | 98,214 |
| 2024-01-03 | Ludwig Jeffrey Jerome Chief Commercial Officer | Sale 10b5-1 | −12,956 | $4.49 | $58K | 99,970 |
| 2024-01-03 | AUERBACH ALAN H President and CEO | Sale 10b5-1 | −41,396 | $4.49 | $186K | 6,936,947 |
Page 5 of 7 · 137 trades